Literature DB >> 17019737

Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia.

Amitabh Chak1, Ashley Faulx, Charis Eng, William Grady, Margaret Kinnard, Heather Ochs-Balcom, Gary Falk.   

Abstract

BACKGROUND: The efficacy of endoscopic screening for chronic gastroesophageal reflux symptoms of heartburn and regurgitation in adult subjects depends on the sensitivity of this strategy for detecting Barrett esophagus in subjects before the development of adenocarcinoma of the esophagus or cardia. The aim of the current study was to determine what proportion of patients with cancer of the esophagus or cardia would have been candidates for a screening endoscopy before their cancer diagnosis based on the presence and duration of preceding reflux symptoms.
METHODS: All patients with adenocarcinoma of the esophagus, adenocarcinoma of the cardia, or long-segment Barrett esophagus presenting for endoscopy at 4 tertiary care and 2 Veterans Affairs (VA) hospitals were given a previously validated questionnaire to determine their recall of common gastroesophageal reflux symptoms.
RESULTS: The study population of 375 subjects consisted primarily of 294 (78%) white men. Only 67 of 110 patients (61%) with adenocarcinoma of the esophagus and 8 of 21 patients (38%) with adenocarcinoma of the cardia recalled symptoms of heartburn or regurgitation being present for >5 years before their diagnosis of cancer. Only 40 of 110 patients (36%) with adenocarcinoma of the esophagus and 5 of 21 patients (24%) with adenocarcinoma of the cardia recalled weekly symptoms being present for >5 years before their cancer diagnosis. Of the 244 patients with Barrett esophagus, 170 (70%) recalled heartburn or regurgitation for >5 years and 89 patients (37%) recalled weekly symptoms for >5 years.
CONCLUSIONS: Current practice, which uses a screening strategy of performing endoscopy in patients with >5 years of heartburn or regurgitation, can detect Barrett epithelium in only a limited proportion of those patients at risk for developing adenocarcinoma of the esophagus or adenocarcinoma of the cardia. (c) 2006 American Cancer Society.

Entities:  

Mesh:

Year:  2006        PMID: 17019737     DOI: 10.1002/cncr.22245

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  34 in total

1.  Novel Screening Alternatives for Barrett Esophagus.

Authors:  Apoorva Krishna Chandar; Anamay Sharma; Amitabh Chak
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-05

2.  Association of insulin and insulin-like growth factors with Barrett's oesophagus.

Authors:  Katarina B Greer; Cheryl L Thompson; Lacie Brenner; Beth Bednarchik; Dawn Dawson; Joseph Willis; William M Grady; Gary W Falk; Gregory S Cooper; Li Li; Amitabh Chak
Journal:  Gut       Date:  2011-09-19       Impact factor: 23.059

Review 3.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

4.  The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data.

Authors:  T J Hayeck; C Y Kong; S J Spechler; G S Gazelle; C Hur
Journal:  Dis Esophagus       Date:  2010-03-26       Impact factor: 3.429

5.  Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma.

Authors:  Chin Hur; Tristan J Hayeck; Jennifer M Yeh; Ethan M Richards; Ethan B Richards; Stuart J Spechler; G Scott Gazelle; Chung Yin Kong
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

Review 6.  Barrett's esophagus: diagnosis and management.

Authors:  Swathi Eluri; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2017-01-18       Impact factor: 9.427

Review 7.  [Barrett's esophagus].

Authors:  J Labenz
Journal:  Internist (Berl)       Date:  2016-11       Impact factor: 0.743

Review 8.  Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma.

Authors:  Jacquelyn S Carr; Syed F Zafar; Nabil Saba; Fadlo R Khuri; Bassel F El-Rayes
Journal:  J Gastrointest Cancer       Date:  2013-06

Review 9.  Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus.

Authors:  Justin B Taylor; Joel H Rubenstein
Journal:  Am J Gastroenterol       Date:  2010-05-18       Impact factor: 10.864

10.  Is Mass Screening for Barrett's Esophagus a Myth or Reality?

Authors:  Prashanthi N Thota; Amitabh Chak
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-26       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.